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Summary Background. Patients with psoriasis have a level of physical activity below that
recommended for cardiovascular health, which is significantly limited by disease
severity and other psoriasis-specific barriers. We hypothesized that physical activity
is important for cardiovascular health in patients with psoriasis and that its objective
measurement could have clinical utility.
Aim. To explore whether physical activity influences the risk of cardiovascular dis-
ease (CVD) in patients with psoriasis.
Methods. In total, 242 patients with chronic plaque psoriasis were recruited. His-
tory, examination and physical activity were assessed and arteriography, the nonin-
vasive measurement of arterial function, was performed for each participant.
Results. We observed a significant relationship between volume of physical activity
and the likelihood of future CVD as measured by pulse wave velocity (PWV;
P < 0.02). We identified a significant relationship between the diastolic reflection
area (DRA) and health-promoting levels of physical activity (P < 0.001), in addition
to a significant correlation between DRA and the likelihood of future CVD
(P < 0.001). The DRA is a complex, dimensionless variable that describes the inten-
sity of diastolic wave reflection and the duration of diastole, which are key determi-
nants of the blood supply to the left ventricle. Our data suggest that DRA may
represent a surrogate marker for cardiorespiratory fitness.
Conclusion. Our study describes a significant relationship between exercise, car-
diorespiratory fitness and PWV, a preclinical indicator of future CVD risk, in patients
with psoriasis. The DRA offers a noninvasive, objective measurement of exercise
adherence, which could have clinical utility in the future.
Introduction
Psoriasis has serious systemic associations, including
an increased risk of cardiovascular disease (CVD).1
Traditional risk factors for CVD such as obesity,
hypertension and insulin resistance are highly preva-
lent in the psoriasis population, and their detrimental
effect on cardiac health may be compounded by psy-
chological distress and lifestyle choices made by
patients.2
Guidelines for physical activity in the UK are similar
to those from the American Heart Association (AHA),
who recommend that healthy adults, aged 18–
65 years, should expend ≥ 500–1000 metabolic
equivalent-minutes (MET-min)/week, computed from
the energy requirements for an activity (MET),
weighted by duration (min/week).3 Physical activity
promotes healthy body mass index (BMI), lowers blood
pressure, improves self-confidence and reduces stress.4
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However, the health-promoting levels of exercise for
patients with psoriasis are significantly limited by a
number of psoriasis-specific barriers including severity,
treatments, skin sensitivity, clothing choice and partic-
ipation in social/leisure activities; potentially augment-
ing the increased risk of CVD in patients with
psoriasis.5
Pulse wave velocity (PWV), a measure of arterial
stiffness with a prospectively validated relationship to
CVD risk,6 can be significantly improved through aero-
bic activity.7 Studies suggest that moderate to severe
chronic plaque psoriasis may be independently associ-
ated with increased arterial stiffness,8 although the
effect of physical activity on arterial stiffness in psoriasis
is not known. Arterial stiffness increases the velocity of
the aortic pulse wave in both forward and reflected
components. Increased arterial stiffness promotes early
arrival of the reflected wave in systole instead of dias-
tole, resulting in increased systolic arterial pressure,
reduced diastolic aortic pressure,9 and mismatched
myocardial oxygen requirement and perfusion.10 Dias-
tolic reflection area (DRA), a complex dimensionless
variable, describes these key determinants of left ven-
tricular function, with higher DRA indicating better
coronary perfusion.11 DRA is significantly higher in
people who exercise, suggesting that it may objectively
quantify volume of physical activity undertaken.12
The aim of this study was to explore whether physical
activity influences CVD risk in patients with psoriasis.
We hypothesized that physical activity is important for
cardiovascular health in patients with psoriasis, and that
objective measurement of activity has clinical utility.
Methods
The study was approved by the local research ethics
committee (11/NW/0654, 12/NW/0239, 10/H1003/
10) and was conducted in accordance with the Decla-
ration of Helsinki principles. Written informed consent
was obtained from all participants.
Study population
Participants with chronic plaque psoriasis (aged
≥ 18 years) were recruited from a regional psoriasis
clinic in northwest England and from primary care
centres with the same geographical footprint.
Questionnaires
A clinical history was taken from each participant and
assessments of Psoriasis Area and Severity Index
(PASI) (scale 0–72 points) and Dermatology Life Qual-
ity Index (DLQI) (0–30 points)13 were documented.
The short version of the International Physical Activ-
ity Questionnaire (IPAQ) questionnaire (scale 0–
18 900 MET-min/week)14 was completed, generating
categorical scores for activity (low, moderate or high
levels) and continuous scores for intensity [walking
(slow), moderate (brisk walking, doubles tennis) and
vigorous activity (hiking, jogging, fast cycling, singles
tennis) in MET-min/week] (Table 1).3,14
Arterial function assessment
Participants underwent noninvasive measurement of
arterial function (Arteriograph; Tensiomed Ltd, Buda-
pest, Hungary), which uses brachial artery oscillome-
try to calculate PWV (normal range 7–9.7 m/s) and
DRA (normal > 40).9,15 Briefly, the jugulum–symph-
ysis distance was measured and entered into the
device. The arteriograph cuff was placed on the
patient’s upper arm and inflated. Pressure variations
Table 1 Methodology used for the computation of the continu-
ous and categorical activity scores using the short-version Inter-
national Physical Activity Questionnaire.
Computations of scores
Continuous activity score, MET-min/week
Intensity of activitya
Walkingb 3.3 9 min walking 9 days walking
Moderatec 4.0 9 min moderate activity 9 days of
moderate activity
Vigorousd 8.0 9 min vigorous activity 9 days of
vigorous activity
Total IPAQ Walking + moderate + vigorous scores
Categorical activity score
Level of activity
Low Individuals who do not meet the criteria
for moderate or vigorous levels of
physical activity
Moderate ≥ 3 days of vigorous-intensity activity,
≥ 20 min/day or ≥ 5 days of
moderate-intensity activity and/or
walking, ≥ 30 min/day or ≥ 5 days of
any combination of walking,
moderate- or vigorous-intensity activities,
achieving ≥ 600 MET-min/week
High Vigorous-intensity activity ≥ 3 days/week,
achieving ≥ 1500 MET-min/week OR
≥ 7 days of any combination of walking,
moderate- or vigorous-intensity activities,
achieving ≥ 3000 MET-min/week
IPAQ, International Physical Activity Questionnaire; MET, meta-
bolic equivalent. aExamples; bwalking slowly; cwalking briskly,
doubles tennis; dhiking, jogging, fast cycling, singles tennis.
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in the cuff were processed by the system software to
produce the arterial function report.
Statistical analysis
Data were recorded and missing observations coded.
Descriptive statistics summarized variables [median
and interquartile range (IQR) for non-normal continu-
ous variables and percentages for categorical vari-
ables]. Participants who achieved a total energy
expenditure of ≥ 500 MET-min/week through
moderate-intensity and/or vigorous-intensity activity
were considered to have met AHA guidelines.7
Spearman correlation determined relationships
between IPAQ and PWV and between IPAQ and DRA.
Kruskal–Wallis test was used to determine differences
in PWV and DRA across categorical levels of activity.
Dunn–Bonferroni testing was used in post hoc analy-
ses. Mann–Whitney U-test was used to assess differ-
ences in DRA between those who adhered (or not) to
AHA guidelines. Spearman correlation examined rela-
tionships between sedentary behaviour and DRA and
between PW and DRA. SPSS Statistics software (V27;
IBM SPSS, Armonk, NY, USA) was used for analyses
and P < 0.05 was considered significant.
Hierarchical multiple regression analysis investi-
gated relationships between cardiovascular health,
measured by PWV, as the dependent (continuous)
variable (Model 1), with the independent (continuous)
variables of self-reported physical activity (IPAQ) and
age. Sex, history of myocardial infarction (MI)/ang-
ina/transient ischaemic attack (TIA) and treatment for
hypertension were included as binary independent
variables. Independent variables were entered sequen-
tially in three blocks: Block 1, age and sex; Block 2,
history of MI/angina/TIA and treatment for hyperten-
sion; and Block 3, physical activity. A second hierar-
chical multiple regression analysis investigated the
relationship between DRA [dependent (continuous)
variable (Model 2)] with the same independent vari-




In total, 242 patients (124 men, and 118 women)
with psoriasis were enrolled (Table 2), of whom 23%
had psoriatic arthritis, 21% had PWV levels indicating
arterial stiffness and 27% had DRA results suggesting
impaired coronary circulation.
Relationship between physical activity and
cardiovascular health in patients with psoriasis
There was a significant (P < 0.01) negative correla-
tion between PWV and vigorous-intensity activity,
with PWV decreasing as the quantity of vigorous-
intensity activity increased indicating a reduced likeli-
hood of CVD. This relationship was stronger in
patients aged < 65 years, and a significant
(P < 0.001) negative correlation was found between
PWV and the amount of vigorous-intensity activity
reported. Analysis by sex and age > 65 years did not
reveal any significant relationships between PWV and
physical activity.
Participants undertaking high levels of physical
activity had significantly reduced PWV compared with
Table 2 Characteristics of the study participants (n = 242).
Parameter Results




Age, years; median (IQR)a 49 (38–59)
Age of psoriasis onset, years; median (IQR)d 21 (14–35)












PWV, m/si 8.2 (6.9–9.6)
DRAg 46 (38.4–54.7)





Total IPAQk 1957.5 (694.8–4135.5)





AHA, American Heart Association; DRA, diastolic reflection area;
IPAQ, International Physical Activity Questionnaire; IQR,
interquartile range; PASI, Psoriasis Area and Severity Index;
PWV, pulse wave velocity. Missing values: anone; b0.4%; c1.2%;
d1.65%; e2.5%; f4.5%; g7%; h8.7%; i9.5%; j9.9%; k15.7%;
l32.6%.
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those undertaking moderate and low levels of activity
(P < 0.02). Post hoc analysis identified significant dif-
ference between those participating in high and mod-
erate levels of activity (adjusted P < 0.03). Those
relationships were replicated in those patients aged
< 65 years (P = 0.01, post hoc analysis adjusted
P < 0.02). There were no significant differences in
patients aged > 65 years.
Relationship between physical activity and markers of
cardiorespiratory fitness in patients with psoriasis
We observed a statistically significant (P = 0.02) cor-
relation between DRA and total IPAQ scores, indicat-
ing that as participation in exercise (of all intensities)
increased, DRA also increased. Similarly, we observed
significant correlation between vigorous-intensity
(P < 0.01) and moderate-intensity activity (P < 0.01)
and DRA.
There was a significant correlation between DRA
and total IPAQ score (P < 0.01), vigorous-intensity
activity (P < 0.01) and moderate-intensity activity
(P = 0.001) in patients aged 18–65 years. Analysis by
sex revealed a significant correlation between DRA
and total IPAQ scores (P < 0.02) for men aged 18–
65 years, and between DRA and both vigorous-
intensity activity (P < 0.01) and moderate-intensity
(P < 0.03) for women aged 18–65 years.
We identified significant difference in DRA across
the three categories of physical activity (P < 0.05).
Post hoc testing identified significant differences in
DRA between low and high levels of activity (adjusted
P < 0.05). This was replicated in patients aged
< 65 years who had significant differences in DRA
and levels of activity (P = 0.03). Post hoc testing iden-
tified significant (adjusted P = 0.04) differences in
DRA between low and high levels of activity.
There was a significant difference between DRA in
patients who met the AHA guidelines and those
who did not, both for the overall group (P < 0.001)
and for patients aged 18–65 years (P = 0.001). We
identified similar relationships between DRA and
adherence to AHA guidelines for women in the over-
all group (P < 0.01) and women aged 18–65 years
(P = 0.01).
We observed significant negative correlations
between DRA and sitting time, meaning that as seden-
tary behaviour increased, DRA decreased, and this
was seen both for the overall group of patients aged
18–65 years (P < 0.04) and for women aged 18–
65 years (P < 0.04).
Relationship between cardiovascular health and
cardiorespiratory fitness in patients with psoriasis
We observed a significant negative correlation between
DRA and PWV, meaning that as DRA increased, PWV
decreased, indicating a reduced likelihood of CVD; this
was seen both for the overall group (P < 0.001) and
for participants aged 18–65 years (P < 0.001).
There was also a significant negative correlation
between DRA and PWV for both men (P < 0.02) and
women (P < 0.01) in the overall group, which was
also observed in the 18–65-year group for women
(P < 0.01) but not for men.
Factors predicting cardiovascular health and
cardiorespiratory fitness in patients with psoriasis
Having found significant relationships between both
patient-reported physical activity and PWV, and
between patient-reported physical activity and DRA,
we investigated whether self-reported physical activity
(IPAQ) was a significant predictor of either variable
after controlling for confounding factors by performing
a hierarchical regression analysis.
Our first model (Fig. 1) explained 36% of the variance
in PWV (P < 0.001). After adjustment for sex, history of
MI/angina/TIA, treatment for hypertension and IPAQ,
we found that age was a significant predictor of PWV,
which increased by 0.06 m/s (P < 0.001) for each year
of life. Similarly, after adjustment for age, sex, history of
MI/angina/TIA and IPAQ, we found that treatment for
hypertension was also a significant predictor of PWV,
which increased by 1.35 m/s (P = 0.001) for those
receiving treatment for hypertension. Self-reported
vigorous-intensity activity explained 0.1% of the varia-
tion in PWV, which was not significant.
Our second model (Fig. 2) explained 32.1% of the
variance in DRA (P < 0.001). After adjustment for sex,
history of MI/angina/TIA, treatment for hypertension
and IPAQ, age was found to be a significant (P < 0.001)
predictor of DRA, with a significant (P < 0.001) reduc-
tion of 0.59 in DRA for each year of life.
These data suggest that self-reported activity is not
a significant predictor of PWA or DRA. The character-
istics of cases omitted due to missing data were similar
to those of the whole group.
Discussion
We found a significant relationship between volume of
physical activity in patients with psoriasis and the
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likelihood of future CVD as measured by PWV. There
was a significant relationship between DRA and physi-
cal activity or adherence to AHA guidelines, and also
a significant correlation between DRA and the likeli-
hood of future CVD. Our data suggest that DRA may
quantify cardiorespiratory fitness and that increased
levels of physical activity could increase fitness and
reduce CVD risk in patients with psoriasis.
An inverse association has been described between
intensity of physical activity and the risk of developing
coronary heart disease, independent of the total vol-
ume of activity, in large cohort studies of healthy
men.16,17 However, individuals with psoriasis have
higher heart rates and systolic blood pressure during
exercise, together with lower heart rate recovery than
healthy individuals.18 Psoriasis plaques limit normal
sweating and heat dissipation, which may reduce tol-
erability of higher exercise intensities in patients,19
suggesting that a tailored approach to engagement
with exercise in the psoriasis population may be
required.
Decreased expression of the inflammatory markers
C-reactive protein and interleukin (IL)-6 following
moderate-intensity to vigorous-intensity activities in
healthy adults has been observed previously,20,21 and
recent investigations concluded that downregulation
of inflammation is greatest in those exercising at
higher intensities.22 Other groups have reported signif-
icant reduction of key inflammatory cytokines such as
tumour necrosis factor-a, IL-6 and interferon-c in
patients with metabolic syndrome following 12-week
exercise interventions.23,24 It is possible that exercise
may ameliorate a proinflammatory phenotype in
patients with psoriasis; evidence has shown that med-
ian skin involvement is 5% among regular exercisers
compared with 10% among nonexercisers.25
Measurement of physical activity is important when
evaluating health behaviours and assessing the effec-
tiveness of exercise interventions within a population.
Self-report questionnaires involve a degree of subjectiv-
ity, while objective measures such as accelerometry or
calorimetry can be time-/cost-intensive and require
Figure 1 The relationship between the dependent variable (pulse wave velocity; PWV) and predictor variables including chronological
age, sex, comorbidities and self-reported physical activity; results from the hierarchical regression analysis (n = 219; missing data
9.5%). Statistically significant values are highlighted in bold. IPAQ, International Physical Activity Questionnaire; MI, myocardial
infarction; TIA, transient ischaemic attack.
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specialist training. Although further calibration is
required (including comparison with accessible proxies
of cardiorespiratory fitness such as waist circumference
and blood pressure), our data suggest that DRA could
offer a bedside measurement of physical activity with
high clinical utility and greater objectivity than self-
report instruments.
This study had some limitations. First, the short-
version IPAQ does not quantify occupational activity
and therefore the influence of this on cardiovascular
health/fitness was beyond the scope of our study.14
Second, our study was based in northwest England,
an area with high levels of socioeconomic depriva-
tion, which may influence exercise adherence and
CVD. To mitigate this, participants were recruited
from both affluent and deprived areas. Third, we did
not formally assess mood (a risk factor for CVD) or
collect data on treatment for psoriasis, which may
have anti-inflammatory/anti-atherosclerotic activity
and may differ between community-based cohorts
(such as ours) and secondary-care cohorts. In
addition, we did not collect data on BMI, diet or eth-
nic background, which are factors that can affect car-
diovascular health and may represent important
confounders. Fourth, we were unable to make a com-
parison with healthy controls, and it remains unclear
whether physical activity advice for patients with pso-
riasis should be different to that of the general popu-
lation. Finally, participants with missing values were
excluded from the analyses; however, the characteris-
tics of those omitted were similar to those of the
whole group and were therefore unlikely to have
biased the results.
Conclusion
Our study describes significant relationships between
exercise, cardiorespiratory fitness and PWV, a preclini-
cal indicator of future CVD risk, in patients with psori-
asis. A tailored approach to increasing physical
activity in the psoriasis population could help diminish
CVD risk. We also propose use of DRA, as a non
Figure 2 The relationship between the dependent variable (diastolic reflection area; DRA) and predictor variables including chronologi-
cal age, sex, comorbidities and self-reported physical activity; results from the hierarchical regression analysis (n = 224; missing data
7.4%). Statistically significant values are highlighted in bold. IPAQ, International Physical Activity Questionnaire; MI, myocardial
infarction; TIA, transient ischaemic attack.
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invasive clinical tool to objectively quantify the
amount of physical activity undertaken, in further
investigations.
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What’s already known about this topic?
• Traditional risk factors for CVD are highly
prevalent in the psoriasis population.
• Owing to a number of psoriasis-specific barriers,
patients with psoriasis have levels of physical
activity below those recommended for cardiovas-
cular health.
What does this study add?
• We report a significant relationship between
volume of physical activity in patients with psori-
asis and the likelihood of future CVD.
• DRA demonstrates significant correlation with
the likelihood of future CVD.
• DRA may represent a surrogate marker for car-
diorespiratory fitness and have clinical utility as a
noninvasive method to objectively quantify the
amount of physical activity undertaken.
• A tailored approach to increasing physical
activity in the psoriasis population could diminish
their CVD risk.
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